Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease

Clinical Research in Cardiology

Volumn 104, Issue 5, 2015, Pages 401-409

  Petrov, George ^a   Kelle, Sebastian ^a   Fleck, Eckart ^a   Wellnhofer, Ernst ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Coronary angiography; Coronary artery disease; Cost effectiveness analysis; Magnetic resonance imaging; Stress

Indexed keywords

CARDIOTONIC AGENT; DOBUTAMINE;

AGED; CINE MAGNETIC RESONANCE IMAGING; COHORT ANALYSIS; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; GERMANY; HUMAN; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; CARDIOTONIC AGENTS; COHORT STUDIES; CORONARY ARTERY DISEASE; COST-BENEFIT ANALYSIS; DOBUTAMINE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84940004956     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0793-0     Document Type: Article

References (34)

1. Banerjee A, Newman DR, Van den Bruel A, Heneghan C (2012) Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies. Int J Clin Pract 66(5):477–492. doi:10.1111/j.1742-1241.2012.02900.x
2. de Jong MC, Genders TS, van Geuns RJ, Moelker A, Hunink MG (2012) Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol 22(9):1881–1895. doi:10.1007/s00330-012-2434-1
3. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460. doi:10.1016/S0140-6736(11)61335-4
4. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50(14):1343–1353. doi:10.1016/j.jacc.2007.06.030
5. Charoenpanichkit C, Hundley WG (2010) The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12:59. doi:10.1186/1532-429X-12-59
6. Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C, Paetsch I, Wellnhofer E, Fleck E, Klein C, Gebker R (2011) Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc Imaging 4(2):161–172. doi:10.1016/j.jcmg.2010.11.012
7. Kelle S, Nagel E, Voss A, Hofmann N, Gitsioudis G, Buss SJ, Chiribiri A, Wellnhofer E, Klein C, Schneeweis C, Egnell C, Vierecke J, Berger A, Giannitsis E, Fleck E, Katus HA, Korosoglou G (2013) A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients. J Am Coll Cardiol 61(22):2310–2312. doi:10.1016/j.jacc.2013.02.063
8. Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M (2013) Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 62(9):826–838. doi:10.1016/j.jacc.2013.03.080
9. Wallner PE, Konski A (2008) A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development. J Am Coll Radiol 5(11):1125–1129. doi:10.1016/j.jacr.2008.06.008
10. Berger ML, Mamdani M, Atkins D, Johnson ML (2009) Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report–Part I. Value Health 12(8):1044–1052. doi:10.1111/j.1524-4733.2009.00600.x
11. Goeree R, Levin L, Chandra K, Bowen JM, Blackhouse G, Tarride JE, Burke N, Bischof M, Xie F, O’Reilly D (2009) Health technology assessment and primary data collection for reducing uncertainty in decision making. J Am Coll Radiol 6(5):332–342. doi:10.1016/j.jacr.2009.01.012
12. Francis SA, Daly C, Heydari B, Abbasi S, Shah RV, Kwong RY (2013) Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:52. doi:10.1186/1532-429X-15-52
13. (2010) Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser 10 (12):1–38
14. Mark DB, Anderson JL, Brinker JA, Brophy JA, Casey DE Jr, Cross RR, Edmundowicz D, Hachamovitch R, Hlatky MA, Jacobs JE, Jaskie S, Kett KG, Malhotra V, Masoudi FA, McConnell MV, Rubin GD, Shaw LJ, Sherman ME, Stanko S, Ward RP (2014) ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol 63(7):698–721. doi:10.1016/j.jacc.2013.02.002
15. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362(10):886–895. doi:10.1056/NEJMoa0907272
16. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Valgimigli M, Claeys MJ, Donner-Banzhoff N, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Husted S, James SK, Kervinen K, Kristensen SD, Maggioni AP, Pries AR, Romeo F, Ryden L, Simoons ML, Steg PG, Timmis A, Yildirir A (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. doi:10.1093/eurheartj/eht296
17. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S, Nagel E (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35. doi:10.1186/1532-429X-15-35
18. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E (1999) Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99(6):763–770
19. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM (2002) Magnetic resonance imaging determination of cardiac prognosis. Circulation 106(18):2328–2333
20. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S, Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA (2010) Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 56(15):1225–1234. doi:10.1016/j.jacc.2010.06.020
21. Yoon YE, Kitagawa K, Kato S, Ishida M, Nakajima H, Kurita T, Ito M, Sakuma H (2012) Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 60(22):2316–2322. doi:10.1016/j.jacc.2012.07.060
22. Plein S, Motwani M (2013) Fractional flow reserve as the reference standard for myocardial perfusion studies: fool’s gold? Eur Heart J Cardiovasc Imaging 14(12):1211–1213. doi:10.1093/ehjci/jet110
23. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van’t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Bruyne B (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 56(3):177–184. doi:10.1016/j.jacc.2010.04.012
24. Miller CD, Case LD, Little WC, Mahler SA, Burke GL, Harper EN, Lefebvre C, Hiestand B, Hoekstra JW, Hamilton CA, Hundley WG (2013) Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging 6(7):785–794. doi:10.1016/j.jcmg.2012.11.022
25. Boldt J, Leber AW, Bonaventura K, Sohns C, Stula M, Huppertz A, Haverkamp W, Dorenkamp M (2013) Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany. J Cardiovasc Magn Reson 15:30. doi:10.1186/1532-429X-15-30
26. Moschetti K, Muzzarelli S, Pinget C, Wagner A, Pilz G, Wasserfallen JB, Schulz-Menger J, Nothnagel D, Dill T, Frank H, Lombardi M, Bruder O, Mahrholdt H, Schwitter J (2012) Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and US health care systems. J Cardiovasc Magn Reson 14:35. doi:10.1186/1532-429X-14-35
27. Walker S, Girardin F, McKenna C, Ball SG, Nixon J, Plein S, Greenwood JP, Sculpher M (2013) Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 99(12):873–881. doi:10.1136/heartjnl-2013-303624
28. Pilz G, Patel PA, Fell U, Ladapo JA, Rizzo JA, Fang H, Gunnarsson C, Heer T, Hoefling B (2011) Adenosine-stress cardiac magnetic resonance imaging in suspected coronary artery disease: a net cost analysis and reimbursement implications. Int J Cardiovasc Imaging 27(1):113–121. doi:10.1007/s10554-010-9645-9
29. Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D (2007) Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess 11(49):iii–iv (ix-115)
30. Wallner PE, Steinberg ML, Konski AA (2011) Controversies in the adoption of new healthcare technologies. Front Radiat Ther Oncol 43:60–78. doi:10.1159/000322401
31. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P (2007) Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health 10(5):336–347. doi:10.1111/j.1524-4733.2007.00187.x
32. Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C (2013) Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions. Clinicoecon Outcomes Res 5:69–85. doi:10.2147/CEOR.S39624
33. Roberts K, Rink B, Harabagiu SM (2013) A flexible framework for recognizing events, temporal expressions, and temporal relations in clinical text. J Am Med Inform Assoc 20(5):867–875. doi:10.1136/amiajnl-2013-001619
34. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O’Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Mancini GB (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359(7):677–687. doi:10.1056/NEJMoa072771